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Introduction
Treatment of infections in the hospital poses some unique 
issues in comparison with treatment of other equally sick 
inpatients without infections.  The diversity of potential 
pathogens for a given infected site (e.g., pneumonia) and 
the changing spectrum of antimicrobial susceptibilities are 
variables generally not encountered with other diseases. 
Infectious diseases may also have distinctly geographical and/
or travel-related aspects as shown by inhaled fungal infections 
such as coccidioidosmycosis from the southwestern United 
States or Ebola virus disease in West Africa.  Communicable 
diseases due to specific infectious agents (e.g., influenza virus, 
methicillin-resistant Staphylococcus aureus (MRSA), extended 
spectrum beta-lactamase-producing gram-negative rod bacteria 
(ESBL-GNR’s), and many other examples) also pose challenges 
in timely diagnosis, infection control, and patient-family-
colleague education.  In the case of Ebola virus, the presence 
of only a few infected individuals in the United States in 2014 
caused nationwide concern among healthcare workers and 
the public. Clinicians, infection control staff and the hospital-
based microbiology laboratory all received many inquiries 
about potential routes of transmission, diagnostic testing, and 
personal protective strategies.  
Antimicrobial therapies, while often remarkably effective, also 
carry the potential for specific adverse events, some infectious. 
These include Clostridium difficile enterocolitis or fungal 
overgrowth when broad spectrum agents are used. The high 
cost of some agents and serious potential organ toxicities are 
additional limiting factors, especially in the absence of a firm 
diagnosis.  Finally, inappropriate utilization of antimicrobial 
agents—including unnecessary use, selection of an overly broad 
spectrum of activity, too long a course, and too high or too low 
a dose—can drive increasing microbial resistance to these drugs 
[1]. 
Having practiced infectious diseases in the hospital setting 
for over 30 years, I have seen the changing role of the clinical 
microbiology laboratory in patient management.  More recently, 
as director of an antimicrobial stewardship program [2] in a 
community teaching hospital, I have also seen firsthand some of 
the pressures and resource limitations affecting our laboratory.  
Everyone, it seems, is being asked to do more with less, and to 
have it done by “yesterday.”  Fortunately, my health system’s 
clinical microbiology laboratory has had very experienced 
leadership and many technicians have over a decade of 
experience in the field.  This helps the hospital and entire health 
system run more smoothly in the face of some of the challenges 
previously detailed.  However, the need to function quickly and 
efficiently will continue to be a priority and warrant careful 
thought and planning in many areas [3, 4, 5].
Timeliness of testing and reporting
Hospitals are now becoming 24/7 operations as there is 
steady pressure to reduce duration of hospitalization.  I have 
seen patients discharged after very short stays, though this is 
sometimes at patient/family insistence rather than as a clinical 
plan.  However, every decision to discharge represents a balance 
between having enough clinical information for diagnosis and 
selecting effective therapy (e.g., an antibiotic) versus how sick 
a patient is and the prognosis for improvement.  Much of this 
pressure is financial and clinicians have in many cases been able 
to both shorten hospitalization and maintain quality of care. 
Examples are higher dose shorter duration oral fluoroquinolone 
regimens and overall shorter durations of intravenous therapy 
for pneumonia than used in the past. These approaches 
have safely reduced the percentage of pneumonia patients 
requiring admission and facilitated earlier discharge of others. 
Unfortunately, this trend has led to microbiology laboratory 
test results sometimes becoming the rate-limiting step in the 
discharge process. For example, consultants may be asked to 
recommend oral therapy for discharge BEFORE pathogens 
have been identified or susceptibilities determined. While 
patients who have defervesced and whose signs and symptoms 
of infection are resolving would seem to be good candidates 
for discharge on oral antimicrobials, there are enough cases of 
bacteria resistant to common oral agents of choice to make this 
risky clinically and medicolegally.
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The best approach from the microbiology bench would therefore 
be to emphasize rapidity of turnaround time on gram stains, 
cultures, and serologies WITHIN REASON.  Rapid diagnostic 
testing is one answer, as in the case of influenza A/B, respiratory 
syncytial virus, and other pathogens for which a timely diagnosis 
may open up outpatient management options and allow very 
specific antimicrobial treatment or simply supportive care. 
Streamlining specimen handling may be another approach. 
My five-hospital health system utilizes a central microbiology 
lab so that specimen transit time has to be considered for most 
of the hospitals.   Local specialized “stat lab” testing is one 
response, depending on cost and efficiency studies.  On the 
other hand, investing in very expensive equipment to speed 
identification of an organism or generate susceptibilities a few 
hours earlier may not be the best investment.  Review of the flow 
of clinical specimens from collection to transport to processing 
to reporting of results indicated getting final results at 3 am 
rather than 6 am probably doesn’t improve efficiency very much. 
Whatever the methods for getting results quickly, the clinical 
benefit is considerably enhanced by interpreting them correctly 
and communicating results effectively [6].
Insuring expertise in interpreting 
results
Two of the trends cited previously also impact the usefulness of 
data coming from the microbiology laboratory.  One is the need 
for prompt reporting of results to clinical services to facilitate 
patient care.  The other is the move to off-site laboratories as 
groups of hospitals consolidate services to contain costs.  The 
days when clinicians dropped by the microbiology lab to chat 
about a case or teams from clinical services routinely rounded 
through the laboratory to exchange information are now less 
common.  Despite this, as laboratory testing becomes more 
specialized and faster, the need to accurately interpret test 
results is ever more important.  
For example, a new generation of rapid diagnostic tests using 
polymerase-chain assays or gene probes can yield results on 
clinical microbiology specimens within hours [6].  However, 
the results may be preliminary and/or incomplete as when a 
specimen is reported as an ESBL-producer without specific 
susceptibilities or as one of a group of similar pathogens 
without definitive identification.  Given the amount of medical 
knowledge that health care providers must keep track of these 
days, it is not surprising that few practitioners can stay current 
on all the advantages and limitations of new microbiologic 
diagnostic studies.  The microbiology laboratory staff is therefore 
increasingly responsible for getting the latest information to the 
right personnel to act on it [7].
In many hospital systems, the availability of rapid diagnostic 
testing has triggered a debate about when results should 
be communicated and who should be responsible for the 
subsequent decision-making.  This includes automated results 
becoming available in the middle of the night.  In many cases 
these can just be reported via the electronic health record for 
interpretation at rounds in the morning.  However, for some 
potentially life-threatening or communicable infectious diseases 
(e.g., bacteremias, positive CSF cultures, some sputum tests, 
etc.) it has been argued that the information should be acted 
on as soon as possible.  The chain of reporting of “stat” results 
may involve nursing, pharmacy, and emergency department/
infectious diseases/pulmonary/other consultants, as well as the 
responsible primary service and microbiology laboratory staff. 
Decisions may involve laboratory personnel explaining results 
versus waiting for a supervisor in the morning.  This is an issue 
of laboratory training and policy [3].  When critical information 
is communicated to hospital clinical staff for decision-making 
such as selection or modification of an antibiotic regimen, who 
must be involved?  In most cases, the decision is easily made 
by the primary service.  However, late at night, especially when 
coverage physicians not familiar with the case are involved or 
the decision rests on incomplete pathogen identification or 
antibiotic susceptibility results, who does the work?  Current 
approaches include programs to educate healthcare providers 
about new diagnostic tests, antibiotic options, and when 
to contact a specialist not currently involved in the case. 
Unresolved issues are how to spread out the on-call burden and 




Further, great patient care relies on communication -- from 
the patient and family to the diagnosing clinicians to the 
treating staff and back again.  Much information is now being 
communicated online, e.g., the electronic health record (EHR) 
and local viewing of radiographic data on personal computers. 
Availability of data almost as quickly as it is generated is 
certainly a great improvement over the old paper report slips 
or once daily printouts of results [8].  However, someone must 
look up the data in the EHR and for certain information such 
as positive blood cultures or sputum acid-fast bacilli smears, 
rapid and accurate reporting to someone in a position to act on 
the results is critical.  Thus, having experienced laboratory staff 
that understand this and get the information to the appropriate 
health care provider(s) can have a positive effect [8].
Even routine reports can provide guidance that improves 
timeliness of patient care.  A gram stain report on sputum can 
provide much information to distinguish oral contamination 
from true infection.  Also, describing growth in “chains” versus 
“clusters” for gram-positive cocci, especially in blood or other 
usually sterile fluids, can get appropriate clinical management 
going earlier.  It goes without saying that this data has to be 
generated by technicians confident in their readings and that 
changes should be flagged, timed and dated.  There have been 
occasional inexperienced laboratory staff that have changed 
readings as from gram-positive to gram-negative or from 
culture-positive to -negative without leaving documentation 
of the change. This can be very harmful to patient care and 
clinician confidence in the laboratory.  This leads to a related 
topic.  Clinicians need to have an understanding what a clinical 
microbiology technician does (e.g., how many minutes’ search 
does it take to declare a sputum acid-fast bacterial smear 
negative) to best use their services.  A microbiology lab staffer 
needs to have an idea why a clinician wants to know ASAP if the 
staphylococcus is coagulase-negative or –positive or whether the 
gram-negative rod is a non-lactose fermenter and how it affects 
clinical decision-making.  Participation of laboratory personnel 
and clinicians in rounds, conferences, or other activities to 
discuss patient management should be encouraged, perhaps in 
more formal settings if casual interactions are no longer feasible 
due to distance, etc.
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Emphasize education
As a result of the previous considerations, everyone in health 
care is (or should be) an educator.  In the case of the clinical 
microbiology laboratory, there is a very important role in 
educating other hospital staff about microbiology findings [9]. 
In some cases, this is one-on-one over the telephone about 
a specific patient’s data or in response to a general question 
about how to interpret an antibiogram.  When communicating 
culture results, explaining current institutional pathogen 
resistance profiles, or fielding a request for specialized testing, 
the challenge is to communicate the answer clearly AND 
GAUGE HOW WELL IT IS UNDERSTOOD [7].  Read back of 
critical results is one way to insure the information was correctly 
communicated and errors avoided.  While laboratory staff in 
academic teaching hospitals are probably used to hearing from 
medical students not quite sure what they are asking about, 
this is not an infrequent occurrence at any hospital.  The classic 
mistake seen by infectious diseases physicians is to be called 
about “the best treatment” for an enterococcal infection.  A little 
research, which fortunately no longer necessitates a trip to the 
patient’s chart or a call to the microbiology lab, reveals that the 
organism is an Enterobacter species.  The proliferation of health 
care extenders (physicians’ assistants, nurse practitioners, 
etc.) mean that staff in the microbiology laboratory should 
be comfortable discussing the significance of a culture with 
polymicrobial growth, multidrug-resistant pathogens (such as 
ESBL-GNR’s), and coagulase-negative staphylococci versus 
Staphylococcus aureus, with individuals of differing levels 
of clinical expertise and experience.   Knowing when to refer 
questions to a laboratory supervisor or specialist service, is also 
key.  This is often the case in which as caller is asking about 
the significance of microbiology results vis-à-vis isolation for 
specific communicable diseases, management of patients with 
unusual pathogens, or serologic testing for exotic diseases. 
The further these questions fall outside of the microbiology 
lab routine, the more an accurate referral (ideally with specific 
contact information) will save time and angst for all concerned.
Think multidisciplinary; embrace 
technology
Just as hospitals are being forced to run continuously, the 
“silo mentality” in which different hospital groups keep to 
themselves is being set aside.  Anyone treating patients with 
infections in the hospital now has to be ready to interact with 
the primary clinicians (both outpatient and hospitalist), 
specialist consultants, infection control practitioners, 
pharmacy, formulary committee, nursing leadership, education 
committee, quality assurance committee, and information 
technology service at a minimum.  Thinking this through 
ahead of time can avoid confusion and more work later on.  For 
example, information on antibiotic susceptibilities, especially 
current trends, could be of interest to not just clinicians, but 
also infection control programs, the pharmacy, and quality 
assurance programs.
Computer software may offer some solutions, such as in flagging 
specific communicable diseases for attention, suppressing 
certain antimicrobial susceptibility results with the guidance 
of the formulary committee, and collecting pathogen frequency 
and resistance trends.  This may allow valuable epidemiologic 
studies to guide future decision-making.  Point of service 
education is also becoming feasible, guiding practitioners 
on antimicrobial costs, reasons for restrictions on specific 
agents, and reporting requirements as they enter orders via the 
computer.  Publishing antibiograms regularly is also useful, as 
much for infection control and formulary committee purposes, 
as for guiding individual practitioners in antimicrobial selection. 
While this can be a time-consuming task, software can be a 
major help in the endeavor.
It has been argued that only death and taxes are certain, but 
I suspect that increasingly rapid changes in the way everyone 
manages data will be a common theme now and in the future. 
Clinical microbiology information is key to treating many 
patients in and out of the hospital, and getting the data to the 
right groups in a timely fashion in as useful a form as possible 
will be more and more critical.  Current efforts support faster 
and more specific diagnosis of infections, when not to use 
antibiotics, earlier use of appropriate antimicrobials, and 
narrowing and stopping therapy as soon as possible.  If done 
prudently, hopefully this will help control and reverse the trend 
toward more resistant pathogens which have fewer options for 
treatment [10].
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